Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 15 open reading frame 61 (C15orf61) is an uncharacterized human protein-coding gene encoding a 157-amino-acid protein, with predicted mitochondrial localization and a conserved domain (DUF4528)[1][2][3]. This protein is ubiquitously expressed, with relatively higher levels in skeletal muscle, fat, and cerebellar brain tissue[1]. It shows strong evolutionary conservation among mammals and contains a predicted signal peptide, one transmembrane region, and rich histidine/arginine/tryptophan content[1]. Its biological function is incompletely understood but it is thought to be involved in mitochondrial bioenergetics and possibly transcriptional regulation, as it has been correlated with mitochondrial respiratory conductance and shown altered expression in several disease models, including autoimmune diseases, mitochondrial dysfunction, and aging[1][2]. There are no known small-molecule drugs or therapeutics targeting C15orf61, nor is there strong evidence to consider it a classic pharmacological target at this time[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 15 open reading frame 61 (C15orf61).